EWSR1 and Ewing sarcoma: However, therapeutic targeting of EWS-FLI1, like therapeutic targeting of other transcription factors, has been challenging, and the current therapy for Ewing sarcoma, which has remained unchanged for the past two decades, consists of cytotoxic chemotherapy in combination with surgery and/or radiation [2,3].